Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)
Public ClinicalTrials.gov record NCT01146652. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Uncontrolled Extension Study Evaluating Efficacy and Safety of SAR153191 in Patients With Active Rheumatoid Arthritis (RA)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Main Study: Primary Objective: Assess the long term safety of sarilumab in participants with rheumatoid arthritis (RA). Secondary Objective: Assess the long term efficacy of sarilumab in participants with RA. Sub-Study: This phase 3, open label sub-study was aimed to assess the usability of PFS-S when used by participants with moderate or severe RA, or their professional or non-professional healthcare providers in an unsupervised real-world situation. To mimic the real-world practice, the sub-study was incorporated into the LTS11210 study without additional visits compared to the scheduled visits in the main study. The duration of this sub-study was 12 weeks.
Study identification
- NCT ID
- NCT01146652
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 2,023 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 21, 2010 (Actual)
- Primary completion
- Dec 31, 2020 (Actual)
- Completion
- Dec 31, 2020 (Actual)
- Last update posted
- Mar 28, 2022
2010 – 2020
United States locations
- U.S. sites
- 75
- U.S. states
- 27
- U.S. cities
- 69
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number 840070 | Anniston | Alabama | 36207 | — |
| Investigational Site Number 840138 | Birmingham | Alabama | 35205 | — |
| Investigational Site Number 840152 | Huntsville | Alabama | 35801 | — |
| Investigational Site Number 840072 | Gilbert | Arizona | 85234 | — |
| Investigational Site Number 840141 | Glendale | Arizona | 85304 | — |
| Investigational Site Number 840134 | Fullerton | California | 92835 | — |
| Investigational Site Number 840008 | La Jolla | California | 92093 | — |
| Investigational Site Number 840135 | San Diego | California | 92120 | — |
| Investigational Site Number 840021 | Santa Maria | California | 94354 | — |
| Investigational Site Number 840100 | Stanford | California | 94305 | — |
| Investigational Site Number 840049 | Upland | California | 91786 | — |
| Investigational Site Number 840151 | Colorado Springs | Colorado | 80903 | — |
| Investigational Site Number 840130 | Lewes | Delaware | 19958 | — |
| Investigational Site Number 840153 | Aventura | Florida | 33180 | — |
| Investigational Site Number 840050 | Clearwater | Florida | 35765 | — |
| Investigational Site Number 840033 | Fort Lauderdale | Florida | 33309 | — |
| Investigational Site Number 840041 | Gainesville | Florida | 32608 | — |
| Investigational Site Number 840067 | Jupiter | Florida | 33458 | — |
| Investigational Site Number 840048 | Miami | Florida | 33155 | — |
| Investigational Site Number 840024 | Naples | Florida | 34102 | — |
| Investigational Site Number 840006 | Orlando | Florida | 32806 | — |
| Investigational Site Number 840128 | Ormond Beach | Florida | 32174 | — |
| Investigational Site Number 840063 | Palm Harbor | Florida | 34684 | — |
| Investigational Site Number 840155 | Palm Harbor | Florida | 34684 | — |
| Investigational Site Number 840060 | Sarasota | Florida | 34239 | — |
| Investigational Site Number 840140 | Tampa | Florida | 33614 | — |
| Investigational Site Number 840126 | Vero Beach | Florida | 32960 | — |
| Investigational Site Number 840003 | Atlanta | Georgia | 30322 | — |
| Investigational Site Number 840028 | Decatur | Georgia | 30033 | — |
| Investigational Site Number 840027 | Marietta | Georgia | 30060 | — |
| Investigational Site Number 840018 | Idaho Falls | Idaho | 83404 | — |
| Investigational Site Number 840046 | Chicago | Illinois | 60612 | — |
| Investigational Site Number 840052 | Kansas City | Kansas | 66160-7321 | — |
| Investigational Site Number 840230 | Elizabethtown | Kentucky | 42701 | — |
| Investigational Site Number 840015 | Lexington | Kentucky | 40504 | — |
| Investigational Site Number 840120 | Baton Rouge | Louisiana | 70809 | — |
| Investigational Site Number 840109 | Lake Charles | Louisiana | 70601 | — |
| Investigational Site Number 840055 | Frederick | Maryland | 21702 | — |
| Investigational Site Number 840013 | Wheaton | Maryland | 20902 | — |
| Investigational Site Number 840154 | Boston | Massachusetts | 02115 | — |
| Investigational Site Number 840150 | Lansing | Michigan | 48910 | — |
| Investigational Site Number 840137 | Saint Clair Shores | Michigan | 48081 | — |
| Investigational Site Number 840112 | Lincoln | Nebraska | 68516 | — |
| Investigational Site Number 840026 | Freehold | New Jersey | 07728 | — |
| Investigational Site Number 840115 | Lake Success | New York | 11042 | — |
| Investigational Site Number 840056 | New York | New York | 10003 | — |
| Investigational Site Number 840043 | New York | New York | 11201 | — |
| Investigational Site Number 840106 | Orchard Park | New York | 14127 | — |
| Investigational Site Number 840118 | Smithtown | New York | 11787 | — |
| Investigational Site Number 840116 | Wilmington | North Carolina | 28401 | — |
| Investigational Site Number 840233 | Minot | North Dakota | 58701 | — |
| Investigational Site Number 840002 | Oklahoma City | Oklahoma | 73103 | — |
| Investigational Site Number 840127 | Oklahoma City | Oklahoma | 73103 | — |
| Investigational Site Number 840011 | Tulsa | Oklahoma | 74104 | — |
| Investigational Site Number 840065 | Tulsa | Oklahoma | 74135 | — |
| Investigational Site Number 840010 | Bethlehem | Pennsylvania | 18015 | — |
| Investigational Site Number 840009 | Duncansville | Pennsylvania | 16635 | — |
| Investigational Site Number 840062 | Reading | Pennsylvania | 19611 | — |
| Investigational Site Number 840058 | Columbia | South Carolina | 29204 | — |
| Investigational Site Number 840016 | North Charleston | South Carolina | 29406 | — |
| Investigational Site Number 840025 | Jackson | Tennessee | 38305 | — |
| Investigational Site Number 840059 | Memphis | Tennessee | 38119 | — |
| Investigational Site Number 840032 | Amarillo | Texas | 79124 | — |
| Investigational Site Number 840038 | Austin | Texas | 78705 | — |
| Investigational Site Number 840001 | Dallas | Texas | 75231 | — |
| Investigational Site Number 840022 | Dallas | Texas | 75235 | — |
| Investigational Site Number 840012 | Dallas | Texas | 75390 | — |
| Investigational Site Number 840129 | Houston | Texas | 77074 | — |
| Investigational Site Number 840069 | Lubbock | Texas | 79424 | — |
| Investigational Site Number 840074 | Mesquite | Texas | 75150 | — |
| Investigational Site Number 840020 | Nassau Bay | Texas | 77058 | — |
| Investigational Site Number 840103 | San Antonio | Texas | 78217 | — |
| Investigational Site Number 840036 | Spokane | Washington | 99204 | — |
| Investigational Site Number 840061 | Tacoma | Washington | 98405 | — |
| Investigational Site Number 840124 | Clarksburg | West Virginia | 26301 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 260 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01146652, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 28, 2022 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01146652 live on ClinicalTrials.gov.